Date Filed | Type | Description |
01/04/2023 |
4
| Singh Vanila (Director) has filed a Form 4 on Virpax Pharmaceuticals, Inc.
Txns:
| Granted 15,000 options to buy
@ $0.622, valued at
$9.3k
|
|
03/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/31/2022 |
4
| Singh Vanila (Director) has filed a Form 4 on BIODELIVERY SCIENCES INTERNATIONAL INC
Txns:
| Granted 85,760 options to buy
@ $0 Granted 15,369 restricted stock units
@ $0 Exercised 7,684 restricted stock units
@ $0 |
|
01/05/2022 |
4
| Singh Vanila (Director) has filed a Form 4 on Virpax Pharmaceuticals, Inc.
Txns:
| Granted 12,091 options to buy
@ $3.43, valued at
$41.5k
|
|
11/23/2021 |
4
| Singh Vanila (Director) has filed a Form 4 on BIODELIVERY SCIENCES INTERNATIONAL INC
Txns:
| Exercised 5,333 restricted stock units
@ $0 |
|
08/25/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/09/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/16/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
11/27/2020 |
4
| Singh Vanila (Director) has filed a Form 4 on BIODELIVERY SCIENCES INTERNATIONAL INC
Txns:
| Exercised 5,333 restricted stock units
@ $0 |
|
08/11/2020 |
4
| Singh Vanila (Director) has filed a Form 4 on BIODELIVERY SCIENCES INTERNATIONAL INC
Txns:
| Exercised 6,751 restricted stock units
@ $0 |
|
08/03/2020 |
4
| Singh Vanila (Director) has filed a Form 4 on BIODELIVERY SCIENCES INTERNATIONAL INC
Txns:
| Granted 81,008 options to buy
@ $4.36, valued at
$353.2k
Granted 13,501 restricted stock units
@ $0 |
|
12/09/2019 |
4
| Singh Vanila (Director) has filed a Form 4 on BIODELIVERY SCIENCES INTERNATIONAL INC
Txns:
| Granted 96,000 options to buy
@ $5.85, valued at
$561.6k
Granted 16,000 restricted stock units
@ $0 |
|
12/03/2019 |
3
| Singh Vanila (Director) has filed a Form 3 on BIODELIVERY SCIENCES INTERNATIONAL INC |